Nab-Preventing neutralizing antibody formation in MS pts treated with subcutaneous Interferon beta Ia (Rebif)
|Effective start/end date||10/1/04 → 1/20/10|
- SERONO LAB INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.